We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Multipurpose Biosensors Rely on Luciferase to Light up Target Molecules

By LabMedica International staff writers
Posted on 05 Aug 2015
Print article
Image: This is an example of the type of luminescence produced by chemical modification of luciferase. Key: -S, a tube without streptavidin; +S, with streptavidin (Photo courtesy of Dr. Kai Johnsson, Ecole Polytechnique Fédérale de Lausanne).
Image: This is an example of the type of luminescence produced by chemical modification of luciferase. Key: -S, a tube without streptavidin; +S, with streptavidin (Photo courtesy of Dr. Kai Johnsson, Ecole Polytechnique Fédérale de Lausanne).
A team of Swiss molecular biologists developed a luminescent marker system that sends out a light signal after binding to a specific target molecule.

Investigators at Ecole Polytechnique Fédérale de Lausanne (Switzerland) attached a small chemical tag to the enzyme luciferase, which catalyzes the light produced by fireflies. The tag molecule prevented luciferase from producing light, but when the tag detected its target protein, it released luciferase and attached to that protein instead. As a result, luciferase was free to emit a light, which was the signal that the target molecule had been found.

As proof-of-principle the investigators described in the July 22, 2015, online edition of the journal Nature Communications a luciferase controlled by human carbonic anhydrase whose activity could be controlled by proteins or small molecules in vitro and on living cells, and novel fluorescent and bioluminescent biosensors.

"You can think of the tagged luciferase as a cyborg molecule," said senior author Dr. Kai Johnsson, professor of chemistry at Ecole Polytechnique Fédérale de Lausanne. "Half bio, half synthetic. How could you make luciferase sensitive to the presence of another protein just through mutations? It is a lot of work. With this chemical trick, all we have to worry about is designing an appropriate tag that can recognize the target protein. This is a generalized design. It shows how you can exploit synthetic chemistry to create sophisticated biosensor proteins."

Related Links:
Ecole Polytechnique Fédérale de Lausanne


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.